Ischemic acute renal failure (ARF) is a highly complex disorder involving renal vasoconstriction, filtration failure, tubular obstruction, tubular backleak and generation of reactive oxygen species. Due to this complexity, the aim of our study was to explore effects of Angiotensin II type 1 receptor (AT1R) blockade on kidney structure and function, as well as oxidative stress in spontaneously hypertensive rats (SHR) after renal ischemia reperfusion injury. Experiments were performed on anaesthetized adult male SHR in the model of ARF with 40 minutes clamping the left renal artery. The right kidney was removed and 40 minutes renal ischemia was performed. Experimental groups received AT1R antagonist (Losartan) or vehicle (saline) in the femoral vein 5 minutes before, during and 175 minutes after the period of ischemia. Biochemical parameters were measured and kidney specimens were collected 24h after reperfusion. ARF significantly decreased creatinine and urea clearance, increased LDL and lipid peroxidation in plasma. Treatment with losartan induced a significant increase of creatinine and urea clearance, as well as HDL. Lipid peroxidation in plasma was decreased and catalase enzyme activity in erythrocytes was increased after losartan treatment. Losartan reduced cortico-medullary necrosis and tubular dilatation in the kidney. High expression of pro-apoptotic Bax protein in the injured kidney was downregulated after losartan treatment. Our results reveal that angiotensin II (via AT1R) mediates the most postischemic injuries in hypertensive kidney through oxidative stress enhancement. Therefore, blockade of AT1R may have beneficial effects in hypertensive patients who have developed ARF.
References
[1]
Abernethy VE, Lieberthal W (2002) Acute renal failure in the critically ill patient. Crit Care Clin 18: 203–222, v. doi: 10.1016/s0749-0704(01)00002-1
[2]
Inal M, Altinisik M, Bilgin MD (2002) The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 20: 291–296. doi: 10.1002/cbf.953
[3]
Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, et al. (2000) Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 11: 454–467.
[4]
Kontogiannis J, Burns KD (1998) Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 274: F79–90.
[5]
Fang F, Liu GC, Zhou X, Yang S, Reich HN, et al. (2013) Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury. PLoS One 8: e71433. doi: 10.1371/journal.pone.0071433
[6]
Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916–1923. doi: 10.1172/jci118623
[7]
Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, et al. (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985–17990. doi: 10.1681/asn.2006121393
[8]
Miloradovic Z, Jerkic M, Jovovic D, Mihailovic-Stanojevic N, Milanovic JG, et al. (2007) Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade. Nephrol Dial Transplant 22: 2476–2484. doi: 10.1093/ndt/gfm213
[9]
Wolf G, Wenzel U, Jablonski K, Brundert M, Rinninger F (2005) Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells. Nephrol Dial Transplant 20: 1222–1227. doi: 10.1093/ndt/gfh727
[10]
Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, et al. (2003) High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J Am Soc Nephrol 14: 1833–1843. doi: 10.1097/01.asn.0000075552.97794.8c
[11]
Fortuno MA, Ravassa S, Etayo JC, Diez J (1998) Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT1 blockade with losartan. Hypertension 32: 280–286. doi: 10.1161/01.hyp.32.2.280
[12]
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–358. doi: 10.1016/0003-2697(79)90738-3
[13]
Beutler E (1982) Catalase. In: Beutler E, editor. Red cell metabolism, a manual of biochemical methods. Grune and Stratton, New York, pp 105–106.
[14]
Glatzle D, Vuilleumier JP, Weber F, Decker K (1974) Glutathione reductase test with whole blood, a convenient procedure for the assessment of the riboflavin status in humans. Experientia 30: 665–667. doi: 10.1007/bf01921531
[15]
McCord JM, Fridovich I (1969) The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 244: 6056–6063.
[16]
Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158–169.
[17]
Bayrak O, Uz E, Bayrak R, Turgut F, Atmaca AF, et al. (2008) Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J Urol 26: 285–291. doi: 10.1007/s00345-008-0253-4
[18]
Ritz E, Haxsen V (2003) Angiotensin II and oxidative stress: an unholy alliance. J Am Soc Nephrol 14: 2985–2987. doi: 10.1097/01.asn.0000096784.86791.21
[19]
Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC (2005) Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46: 943–947. doi: 10.1161/01.hyp.0000174602.59935.d5
[20]
Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, et al. (2003) Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 42: 905–910. doi: 10.1016/s0735-1097(03)00846-5
[21]
Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, et al. (1998) Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32: 488–495. doi: 10.1161/01.hyp.32.3.488
[22]
Xu X, Zhao W, Wan W, Ji LL, Powers AS, et al. (2010) Exercise training combined with angiotensin II receptor blockade reduces oxidative stress after myocardial infarction in rats. Exp Physiol 95: 1008–1015. doi: 10.1113/expphysiol.2010.054221
[23]
Bowmer CJ, Nichols AJ, Warren M, Yates MS (1983) Cardiovascular responses in rats with glycerol-induced acute renal failure. Br J Pharmacol 79: 471–476. doi: 10.1111/j.1476-5381.1983.tb11020.x
[24]
Radovic M, Miloradovic Z, Popovic T, Mihailovic-Stanojevic N, Jovovic D, et al. (2006) Allopurinol and enalapril failed to conserve urinary NOx and sodium in ischemic acute renal failure in spontaneously hypertensive rats. Am J Nephrol 26: 388–399. doi: 10.1159/000094936
[25]
Ivanov M, Mihailovic-Stanojevic N, Grujic Milanovic J, Jovovic D, Miloradovic Z (2011) Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failure. Acta Physiol Hung 98: 1–7. doi: 10.1556/aphysiol.98.2011.1.1
[26]
Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1: 16–19. doi: 10.1016/s0140-6736(75)92376-4
[27]
Jerkic M, Miloradovic Z, Jovovic D, Mihailovic-Stanojevic N, Elena JV, et al. (2004) Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure. Nephrol Dial Transplant 19: 83–94. doi: 10.1093/ndt/gfg521
[28]
Silici S, Ekmekcioglu O, Kanbur M, Deniz K (2011) The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats. World J Urol 29: 127–132. doi: 10.1007/s00345-010-0543-5
[29]
Kyriazis I, Kagadis GC, Kallidonis P, Georgiopoulos I, Marazioti A, et al. (2013) PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection? World J Urol 31: 597–602. doi: 10.1007/s00345-012-0980-4
[30]
Heeba GH (2011) Angiotensin II receptor blocker, losartan, ameliorates gentamicin-induced oxidative stress and nephrotoxicity in rats. Pharmacology 87: 232–240. doi: 10.1159/000325457
[31]
Therrien F, Lemieux P, Belanger S, Agharazii M, Lebel M, et al. (2009) Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol 607: 126–134. doi: 10.1016/j.ejphar.2009.01.040
[32]
Aizawa T, Ishizaka N, Kurokawa K, Nagai R, Nakajima H, et al. (2001) Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats. Kidney Int 59: 645–653. doi: 10.1046/j.1523-1755.2001.059002645.x
